27 January 2026 : Database Analysis
Comparison of Outcomes From Intermittent Hemodialysis and Continuous Renal Replacement Therapy With Systemic or Regional Anticoagulation in 128 Patients in a Polish Intensive Care Unit
Joanna Wolska
ABCDEF 1,2*, Dariusz Onichimowski ACD 1,2, Milena Samiec E 1,3, Iwona Podlińska E 1,3, Paweł Radkowski E 1,3
DOI: 10.12659/MSM.949686
Med Sci Monit 2026; 32:e949686
Table 1 Distribution of chronic diseases and vasoconstrictors use in the study population according to groups: IHD, HEP, and CITR.
| Variable | IHD | HEP | CITR | Test result | P value | |||
|---|---|---|---|---|---|---|---|---|
| N | % | N | % | N | % | |||
| HT | ||||||||
| No | 35 | 85.37% | 26 | 65.00% | 29 | 61.70% | 6.661 | |
| Yes | 6 | 14.63% | 14 | 35.00% | 18 | 38.30% | ||
| DM | ||||||||
| No | 39 | 95.12% | 31 | 77.50% | 40 | 85.11% | 5.245 | 0.073 |
| Yes | 2 | 4.88% | 9 | 22.50% | 7 | 14.89% | ||
| SURG | ||||||||
| No | 9 | 21.95% | 17 | 42.50% | 13 | 27.66% | 4.312 | 0.116 |
| Yes | 32 | 78.05% | 23 | 57.50% | 34 | 72.34% | ||
| Liver failure | ||||||||
| No | 32 | 78.05% | 36 | 90.00% | 42 | 89.36% | 3.114 | 0.211 |
| Yes | 9 | 21.95% | 4 | 10.00% | 5 | 10.64% | ||
| Vasoconstrictors use | ||||||||
| No | 5 | 12.20% | 2 | 5.00% | 3 | 6.38% | 1.671 | 0.434 |
| Yes | 36 | 87.80% | 38 | 95.00% | 44 | 93.62% | ||
| Pearson chi-square test. CITR – patients receiving continuous renal replacement therapy with citrate anticoagulation; DM – diabetes mellitus; HEP – patients subject to continuous renal replacement therapy with heparin anticoagulation; HT – arterial hypertension; IHD – patients subject to intermittent hemodialysis; SURG – patient after surgical procedure. | ||||||||